|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: MEGO FINANCIAL CORP, 10-K, EX-10.220, 2000-11-29 |
Next: ALLIANCE PHARMACEUTICAL CORP, S-4/A, 2000-11-29 |
<TABLE> <S> <C>
<ARTICLE> 5
<MULTIPLIER> 1,000
<S> <C>
<PERIOD-TYPE> 12-MOS
<FISCAL-YEAR-END> AUG-31-2000
<PERIOD-START> SEP-01-1999
<PERIOD-END> AUG-31-2000
<CASH> 2,324
<SECURITIES> 0
<RECEIVABLES> 96,390
<ALLOWANCES> 13,234
<INVENTORY> 27,420
<CURRENT-ASSETS> 0
<PP&E> 40,799
<DEPRECIATION> 17,632
<TOTAL-ASSETS> 168,592
<CURRENT-LIABILITIES> 0
<BONDS> 109,131
0
0
<COMMON> 35
<OTHER-SE> 25,747
<TOTAL-LIABILITY-AND-EQUITY> 168,592
<SALES> 68,686
<TOTAL-REVENUES> 90,495
<CGS> 13,568
<TOTAL-COSTS> 55,035
<OTHER-EXPENSES> 32,041
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 12,468
<INCOME-PRETAX> 3,419
<INCOME-TAX> (530)
<INCOME-CONTINUING> 3,419
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 3,949
<EPS-BASIC> 1.13
<EPS-DILUTED> 1.13
</TABLE>
|
|